Search

Meeting Coverage:

EURETINA Congress

EURETINA: 2022

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

Show Description +

Anat Loewenstein, MD, MHA, talks with Dinah Zur, MD, about the differences between neovascularization and central serous chorioretinopathy and how retina specialists can be confident in the right diagnosis.

Posted: 10/18/2022

Keywords:

Central Serous Choroidopathy, CSC

•

Type 1 Neovascularization

•

Neovascularization

•

retina-meeting-recap

Up Next

A Word From Euretina's President

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD

Gearing Up for a GA Therapy

Gearing Up for a GA Therapy

Kourous A. Rezaei, MD; and Anat Loewenstein, MD, MHA

Using AI for DR Screening in India

Using AI for DR Screening in India

S. Natarajan, MBBS, DO, FICO (UK), FVRS; and Andrzej Grzybowski, MD, PhD, MBA

Steps to Achieving the Impossible in DR Management

Steps to Achieving the Impossible in DR Management

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth

The Coming Shift in AMD Care

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Treating Traumatic Aphakia and Aniridia

Treating Traumatic Aphakia and Aniridia

Matteo Forlini, MD; and Mario R. Romano, MD, PhD

CRISPR/Cas9 Shows Promise for Patients with LCA

CRISPR/Cas9 Shows Promise for Patients with LCA

Mark E. Pennesi, MD, PHD

Back to All Videos

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

Anat Loewenstein, MD, MHA, talks with Dinah Zur, MD, about the differences between neovascularization and central serous chorioretinopathy and how retina specialists can be confident in the right diagnosis.

Posted: 10/18/2022

Keywords:

Central Serous Choroidopathy, CSC

•

Type 1 Neovascularization

•

Neovascularization

•

retina-meeting-recap

Please log in to leave a comment.

More From EURETINA: 2022 Coverage

The Coming Shift in AMD Care

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Treating Traumatic Aphakia and Aniridia

Treating Traumatic Aphakia and Aniridia

Matteo Forlini, MD; and Mario R. Romano, MD, PhD

CRISPR/Cas9 Shows Promise for Patients with LCA

CRISPR/Cas9 Shows Promise for Patients with LCA

Mark E. Pennesi, MD, PHD

A Word From Euretina's President

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of EURETINA: 2022.